Betta Pharmaceuticals Hits Day High with Strong 4.31% Intraday Surge

Betta Pharmaceuticals Co., Ltd. has experienced a notable increase of 4.31% on July 21, 2026, reaching an intraday high of CNY 60.97. This performance stands out against the backdrop of the China Shanghai Composite, which rose by 1.79% on the same day. In terms of broader performance metrics, Betta Pharmaceuticals has shown a year-to-date gain of 29.54%, significantly outperforming the China Shanghai Composite's decline of 2.63%. However, over the past week, the stock has faced a decline of 13.35%, contrasting with the composite's smaller drop of 2.59%. Despite the recent uptick, the company has faced challenges over the longer term, with a one-year performance decline of 7.38%. Financially, Betta Pharmaceuticals holds a market capitalization of CNY 20,232 million and a price-to-earnings ratio of 52.00. The company also maintains a dividend yield of 0.71% and a return on equity of 5.72%. These metrics reflect the company's current market position within the pharmaceuticals and biotechnology industry.